[go: up one dir, main page]

AU2013219148B2 - Uses of DPP-IV inhibitors - Google Patents

Uses of DPP-IV inhibitors

Info

Publication number
AU2013219148B2
AU2013219148B2 AU2013219148A AU2013219148A AU2013219148B2 AU 2013219148 B2 AU2013219148 B2 AU 2013219148B2 AU 2013219148 A AU2013219148 A AU 2013219148A AU 2013219148 A AU2013219148 A AU 2013219148A AU 2013219148 B2 AU2013219148 B2 AU 2013219148B2
Authority
AU
Australia
Prior art keywords
inhibitors
dpp
disclosed
disorders
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013219148A
Other versions
AU2013219148A1 (en
Inventor
Klaus Dugi
Frank Himmelsbach
Michael Mark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007247141A external-priority patent/AU2007247141B2/en
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Priority to AU2013219148A priority Critical patent/AU2013219148B2/en
Publication of AU2013219148A1 publication Critical patent/AU2013219148A1/en
Application granted granted Critical
Publication of AU2013219148B2 publication Critical patent/AU2013219148B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed is the use of selected DPP-IV inhibitors for treating physiological functional disorders and reducing the risk of at-risk patient groups developing such functional 5 disorders. Also disclosed is the use of said DPP-IV inhibitors in combination with other agents such that improved treatment results can be obtained. Said uses can be employed for producing corresponding medicaments.
AU2013219148A 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors Active AU2013219148B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013219148A AU2013219148B2 (en) 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06009203.8 2006-05-04
AU2007247141A AU2007247141B2 (en) 2006-05-04 2007-05-03 Uses of DPP-IV inhibitors
AU2013219148A AU2013219148B2 (en) 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2007247141A Division AU2007247141B2 (en) 2006-05-04 2007-05-03 Uses of DPP-IV inhibitors

Publications (2)

Publication Number Publication Date
AU2013219148A1 AU2013219148A1 (en) 2013-09-05
AU2013219148B2 true AU2013219148B2 (en) 2016-07-14

Family

ID=48444738

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2013203306A Active AU2013203306B2 (en) 2006-05-04 2013-04-10 Uses of DPP-IV inhibitors
AU2013219148A Active AU2013219148B2 (en) 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors
AU2013219147A Active AU2013219147B2 (en) 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2013203306A Active AU2013203306B2 (en) 2006-05-04 2013-04-10 Uses of DPP-IV inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2013219147A Active AU2013219147B2 (en) 2006-05-04 2013-08-19 Uses of DPP-IV inhibitors

Country Status (1)

Country Link
AU (3) AU2013203306B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004044221A1 (en) * 2004-09-14 2006-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 3-methyl-7-butynyl xanthines, their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
AU2013219147B2 (en) 2016-07-14
AU2013203306B2 (en) 2016-07-21
AU2013219147A1 (en) 2013-09-05
AU2013203306A1 (en) 2013-05-02
AU2013219148A1 (en) 2013-09-05

Similar Documents

Publication Publication Date Title
MX2020009911A (en) Uses of dpp-iv inhibitors.
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
MX2010004074A (en) Combination 059.
LUC00011I1 (en)
MXPA05008406A (en) Phenylacetamides and their use as glucokinase modulators.
EP2286839A3 (en) Treatment of obesity and related diseases
WO2008133928A3 (en) Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
GB0416508D0 (en) Therapeutic agents
MXPA05001885A (en) The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis.
SG146451A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
AU2013219148B2 (en) Uses of DPP-IV inhibitors
GB0606015D0 (en) therapeutic agents
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
AU2003229876A1 (en) Tumour associated antigens
GB2445882A (en) Prophylactic and therapeutic agents and uses therefor

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)